查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363322

感染疾病治療市場規模、佔有率和趨勢分析：按疾病類型、最終用途、地區和細分趨勢，2023-2030

Infectious Disease Therapeutics Market Size, Share & Trends Analysis By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV), By End-use (Hospital, Clinics), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 81 Pages | 商品交期: 2-10個工作天內

價格

感染疾病治療市場的成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球感染疾病治療市場規模預計將達到1,152億美元，2023年至2030年年複合成長率為7.1%。

該市場要素受到全球人類免疫力缺乏病毒（HIV）、人類乳突病毒（HPV）、結核病和肝炎病例數量不斷增加的推動。

政府感染疾病和私人公司正在開拓領域進行大量投資，以預防、診斷和治療感染疾病。提高意識提升措施預計將在預測期內提振市場。此外，由於價格下降，專利到期的增加和學名藥進入市場預計將增加對感染疾病治療的需求。

此外，對這些感染疾病的診斷和治療的報銷以及製造商在這些疾病高發地區免費分發藥品也是進一步推動市場成長的要素，值得期待。然而，感染疾病物的低普及和假藥的高流行預計將成為預測期內成長抑制因素。

2016年北美市場佔最大佔有率。大量製造商的存在、有利的報銷方案以及不斷上漲的醫療費用是該地區佔據最大市場佔有率的主要要素。然而，2017 年至 2025 年，亞太地區可能會呈現最高成長率。感染疾病的高患病、亞洲國家經濟狀況的改善、政府採取更多舉措以增加感染疾病治療的採用以及資金籌措活動的增加將活性化預測期內該地區的成長。這是導致最高比率的要素。

感染疾病治療市場報告亮點

  • 2022 年，愛滋病毒領域的收益佔有率最大，為 31.6%。此細分市場的推動因素包括愛滋病毒患病的活性化、對愛滋病毒感染者的資助力度不斷加大、非洲國家免費愛滋病毒自我檢測套組的供應量不斷增加以及世界各地的宣傳活動。這是造成該細分市場成長的主要要素。最大佔有率。
  • 預計 HPV領域在預測期內將以 8.1% 的年複合成長率成長最快。其成長的關鍵要素包括 HPV患病的增加以及用於治療這種感染疾病的藥物成本的下降。
  • 2022年，醫院業務收入佔比最大，為54.5%。報告感染疾病的緊急醫院就診次數的增加是市場的關鍵成長要素。
  • 2022 年，北美地區的收益佔有率最大，達 39.9%。此類疾病的日益患病和有利的報銷方案是推動該地區感染疾病治療需求的主要要素。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 感染疾病治療市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 感染疾病治療市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 感染疾病治療：依疾病類型估計及趨勢分析

  • 感染疾病治療市場：重點
  • 感染疾病治療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • HIV
  • 肝炎
  • 流感
  • 結核
  • 瘧疾
  • HPV

第5章 感染疾病治療：依最終用途分類的估計與趨勢分析

  • 感染疾病治療市場：重點
  • 感染疾病治療市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 診所
  • 其他

第6章 感染疾病治療市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的感染疾病治療市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭分類
    • Novartis AG
    • Gilead
    • GlaxoSmithKline plc
    • Janssen Pharmaceutical, Inc.
    • F. Hoffmann-La Roche Ltd.
    • BioCryst Pharmaceuticals, Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim GmbH
Product Code: GVR-1-68038-580-9

Infectious Disease Therapeutics Market Growth & Trends:

The global infectious disease therapeutics market size is expected to reach USD 115.2 billion by 2030, registering a CAGR of 7.1% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is primarily driven by increasing number of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and hepatitis cases globally.

Government and private organizations are investing heavily in the healthcare sector to prevent, diagnose, and treat infectious diseases; rising investments for development of new drugs to treat infectious diseases, and increasing number of initiatives for creating awareness about these conditions are expected to boost the market during the forecast period. Furthermore, increasing number of patent expirations and entry of generic drugs in the market are expected to increase the demand for infectious disease therapeutics due to their low prices.

In addition, availability of reimbursement for diagnosis & treatment of these infections and free distribution of drugs by manufacturers in regions with high incidence of these diseases are factors further expected to propel the market growth. However, low penetration rate of anti-infective and availability of large number of counterfeit drugs are expected to restraint the market growth during the forecast period.

North American market held the largest share in 2016. Presence of large number of manufacturers, favorable reimbursement scenario, and increasing healthcare expenditure are major factors responsible for the largest share held by this region. However, Asia Pacific is likely to grow at the highest rate between 2017 and 2025. High prevalence of infectious diseases; improving economic conditions in Asian countries, rising government initiatives to increase the adoption of treatments for infectious diseases, and rising funding activities are factors that can be attributed for the highest growth rate of this region during the forecast period.

Infectious Disease Therapeutics Market Report Highlights:

  • The HIV segment held the largest revenue share of 31.6% in 2022. The increasing prevalence of HIV, rising funding activities for patients who have HIV, increasing supply of free HIV self-test kits in African countries, and raising awareness campaigns around the globe are the key factors responsible for the largest share held by this segment.
  • The HPV segment is expected to grow at the fastest CAGR of 8.1% during the forecast period. Major factors that are responsible for its growth include the increasing prevalence of HPV and the low cost of drugs that are used in the treatment of this infection.
  • The hospital's segment held the largest revenue share of 54.5% in 2022. The increasing number of emergency hospital visits reporting infectious diseases is a significant growth factor for the market.
  • North America dominated the market with the largest revenue share of 39.9% in 2022. The increasing prevalence of such disorders and favorable reimbursement scenarios are key factors likely to propel the region's demand for infectious disease therapeutics.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Disease Type
    • 1.1.2. End use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Infectious Disease Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Infectious Disease Therapeutics Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Infectious Disease Therapeutics: Disease Type Estimates & Trend Analysis

  • 4.1. Infectious Disease Therapeutics Market: Key Takeaways
  • 4.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. HIV
    • 4.3.1. HIV market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.4. Hepatitis
    • 4.4.1. Hepatitis market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.5. Influenza
    • 4.5.1. Influenza market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.6. TB
    • 4.6.1. TB market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.7. Malaria
    • 4.7.1. Malaria market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 4.8. HPV
    • 4.8.1. HPV market estimates and forecasts, 2018 to 2030, (USD Billion)

Chapter 5. Infectious Disease Therapeutics: End Use Estimates & Trend Analysis

  • 5.1. Infectious Disease Therapeutics Market: Key Takeaways
  • 5.2. Infectious Disease Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 5.4. Clinics
    • 5.4.1. Clinic market estimates and forecasts, 2018 to 2030, (USD Billion)
  • 5.5. Others
    • 5.5.1. Other market estimates and forecasts, 2018 to 2030, (USD Billion)

Chapter 6. Infectious Disease Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Infectious Disease Therapeutics Market by Region: Key Takeaways
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Novartis AG
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Gilead
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. GlaxoSmithKline plc
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Janssen Pharmaceutical, Inc.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. F. Hoffmann-La Roche Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. BioCryst Pharmaceuticals, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Merck & Co., Inc.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Boehringer Ingelheim GmbH
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 3 North America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 4 North America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 5 U.S. infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 6 U.S. infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 7 Canada infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 8 Canada infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 9 Europe infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 10 Europe infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 11 Europe infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 12 Germany infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 13 Germany infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 14 UK infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 15 UK infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 16 France infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 17 France infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 18 Italy infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 19 Italy infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 20 Spain infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 21 Spain infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 22 Denmark infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 23 Denmark infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 24 Sweden infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 25 Sweden infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 26 Norway infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 27 Norway infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 28 Asia Pacific infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 29 Asia Pacific infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 30 Asia Pacific infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 31 Japan infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 32 Japan infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 33 China infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 34 China infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 35 India infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 36 India infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 37 Australia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 38 Australia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 39 Thailand infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 40 Thailand infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 41 South Korea infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 42 South Korea infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 43 Latin America infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 44 Latin America infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 45 Latin America infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 46 Brazil infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 47 Brazil infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 48 Mexico infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 49 Mexico infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 50 Argentina infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 51 Argentina infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 52 Middle East and Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 53 Middle East and Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 54 Middle East and Africa infectious disease therapeutics market, by region, 2018 - 2030 (USD Billion)
  • Table 55 South Africa infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 56 South Africa infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 57 Saudi Arabia infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 58 Saudi Arabia infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 59 UAE infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 60 UAE infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)
  • Table 61 Kuwait infectious disease therapeutics market, by disease type, 2018 - 2030 (USD Billion)
  • Table 62 Kuwait infectious disease therapeutics market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Infectious disease therapeutics: Market outlook
  • Fig. 8 Infectious disease therapeutics: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Infectious disease therapeutics market driver impact
  • Fig. 14 Infectious disease therapeutics market restraint impact
  • Fig. 15 Infectious disease therapeutics market strategic initiatives analysis
  • Fig. 16 Infectious disease therapeutics market: Disease type movement analysis
  • Fig. 17 Infectious disease therapeutics market: Disease type outlook and key takeaways
  • Fig. 18 HIV market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Hepatitis market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Influenza market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 TB market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Malaria market estimates and forecasts, 2018 - 2030
  • Fig. 23 HPV market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Infectious disease therapeutics market: End Use movement analysis
  • Fig. 25 Infectious disease therapeutics market: End Use outlook and key takeaways
  • Fig. 26 Hospitals market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Clinics market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Global infectious disease therapeutics market: Regional movement analysis
  • Fig. 30 Global infectious disease therapeutics market: Regional outlook and key takeaways
  • Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 56 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Billion)